Increased leukocyte–platelet adhesion in chronic myeloproliferative disorders with high platelet counts

By Kaplar M.   Kappelmayer J.   Kiss A.   Szabo K.   Udvardy M.  

Platelets, Vol. 11, Iss. 3, 2000-05 ,pp. : 183-184

Informa Healthcare

Access to resources Recommend Favorite

In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: Are they laboratory artefacts?

By Grignani Claudio   Noris Patrizia   Tinelli Carmine   Barosi Giovanni   Balduini Carlo  

Platelets, Vol. 20, Iss. 2, 2009-03 ,pp. : 131-134

Informa Healthcare

Access to resources Recommend Favorite

Platelet resistance to the antiaggregating effect of N-acetyl-l-cysteine in obese, insulin-resistant subjects

By Anfossi G.   Russo I.   Massucco P.   Mattiello L.   Trovati M.  

Thrombosis Research, Vol. 110, Iss. 1, 2003-04 ,pp. : 39-46

Elsevier

Access to resources Recommend Favorite

Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes

By Villmow T.   Kemkes-Matthes B.   Matzdorff A.C.  

Thrombosis Research, Vol. 108, Iss. 2, 2002-11 ,pp. : 139-145

Elsevier

Access to resources Recommend Favorite

Further evidence for the regulation of acetyl-CoA carboxylase activity by a glutamate- and magnesium-activated protein phosphatase in the pancreatic β cell: Defective regulation in the diabetic GK rat islet

By Palanivel Rengasamy   Veluthakal Rajakrishnan   McDonald Phillip   Kowluru Anjaneyulu  

Endocrine Journal, Vol. 26, Iss. 1, 2005-02 ,pp. : 71-77

Humana Press, Inc

Access to resources Recommend Favorite